Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EASL Clinical Practice Guidelines on the management of hepatic encephalopathy
Sara Montagnese, Pierre‐Emmanuel Rautou, Manuel Romero‐Gómez, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 3, pp. 807-824
Closed Access | Times Cited: 256

Showing 1-25 of 256 citing articles:

Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies
Marta Maestri, Francesco Santopaolo, Maurizio Pompili, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 49
EASL position paper on clinical follow-up after HCV cure
Thomas Reiberger, Sabela Lens, Giuseppe Cabibbo, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 2, pp. 326-344
Closed Access | Times Cited: 24
Microbiota transplant for hepatic encephalopathy in cirrhosis: The THEMATIC trial
Jasmohan S. Bajaj, Andrew Fagan, Edith Gavis, et al.
Journal of Hepatology (2025)
Closed Access | Times Cited: 3
Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial
Mads Israelsen, Bjørn Stæhr Madsen, Nikolaj Torp, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 6, pp. 523-532
Open Access | Times Cited: 43
Update in the Treatment of the Complications of Cirrhosis
Juan G. Abraldeṣ, Paolo Caraceni, Marwan Ghabril, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 8, pp. 2100-2109
Open Access | Times Cited: 37
Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Multicenter Study
Simon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, et al.
The American Journal of Gastroenterology (2023) Vol. 118, Iss. 12, pp. 2191-2200
Closed Access | Times Cited: 30
Diagnosis and management of hepatic encephalopathy: The French recommendations
Dominique Thabut, Charlotte Bouzbib, Lucy Meunier, et al.
Liver International (2023) Vol. 43, Iss. 4, pp. 750-762
Open Access | Times Cited: 28
Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis
Silvia Nardelli, Oliviero Riggio, Fabio Marra, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 4, pp. 596-602
Open Access | Times Cited: 26
Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis
Harry D Zacharias, Fady Kamel, Jaclyn Tan, et al.
Cochrane library (2023) Vol. 2023, Iss. 7
Closed Access | Times Cited: 25
Gut microbiome-brain-cirrhosis axis
Maren L. Smith, James B. Wade, Jennifer T. Wolstenholme, et al.
Hepatology (2023) Vol. 80, Iss. 2, pp. 465-485
Closed Access | Times Cited: 24
Use of albumin infusion for cirrhosis-related complications: An international position statement
Zhaohui Bai, Nahúm Méndez‐Sánchez, Fernando Gomes Romeiro, et al.
JHEP Reports (2023) Vol. 5, Iss. 8, pp. 100785-100785
Open Access | Times Cited: 24
Comparison of 6 tests for diagnosing minimal hepatic encephalopathy and predicting clinical outcome: A prospective, observational study
Alena F. Ehrenbauer, Julius F.M. Egge, Maria M. Gabriel, et al.
Hepatology (2024) Vol. 80, Iss. 2, pp. 389-402
Closed Access | Times Cited: 12
Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment
Ciro Celsa, Giuseppe Cabibbo, Claudia Angela Maria Fulgenzi, et al.
Hepatology (2024)
Closed Access | Times Cited: 11
Acute and non‐acute decompensation of liver cirrhosis (47/130)
Martin Schulz, Paolo Angeli, Jonel Trebicka
Liver International (2024)
Open Access | Times Cited: 9
A real-world drug safety surveillance study from the FAERS database of hepatocellular carcinoma patients receiving pembrolizumab alone and plus lenvatinib
Huaxiang Wang, Junjun Li, Xiuling Zhu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Vitamin D Supplementation Is Associated with Inflammation Amelioration and Cognitive Improvement in Decompensated Patients with Cirrhosis
Raquel Diaz-Ruiz, María Poca, Eva Román, et al.
Nutrients (2025) Vol. 17, Iss. 2, pp. 226-226
Open Access | Times Cited: 1
Cognitive impairment in alcohol use disorder and clinical practice guidelines for management of long-stay alcohol use disorder patients
Samir Kumar Praharaj, Vikas Menon, Shahul Ameen
Indian Journal of Psychiatry (2025) Vol. 67, Iss. 1, pp. 144-157
Open Access | Times Cited: 1
Correlation of Serum Zinc Levels with Hepatic Encephalopathy Severity in Patients with Decompensated Liver Cirrhosis: A Prospective Observational Study from Egypt
Atteyat A. Semeya, Rasha Elgamal, Amira A. A. Othman
Biological Trace Element Research (2025)
Open Access | Times Cited: 1
Post‐TIPS Overt Hepatic Encephalopathy Increases Long‐Term but Not Short‐Term Mortality in Cirrhotic Patients With Variceal Bleeding: A Large‐Scale, Multicenter Real‐World Study
Yi Xiang, Jun Tie, Guangchuan Wang, et al.
Alimentary Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 1
Liver cirrhosis: Ancient disease, new challenge
Adrià Juanola, Elisa Pose, Pere Ginés
Medicina Clínica (English Edition) (2025)
Closed Access | Times Cited: 1
Minimal Hepatic Encephalopathy in Cirrhotic Patients: A New Simple and Fast Digital Screening Method
Henrike Dobbermann, Raffael Schlüter, Yevgeniy Lyubchenko, et al.
United European Gastroenterology Journal (2025)
Open Access | Times Cited: 1
Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)
Mattias Mandorfer, Elmar Aigner, Manfred Cejna, et al.
Wiener klinische Wochenschrift (2023) Vol. 135, Iss. S3, pp. 493-523
Open Access | Times Cited: 23
Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease
Lorenz Balcar, Julia Krawanja, Bernhard Scheiner, et al.
JHEP Reports (2023) Vol. 5, Iss. 4, pp. 100682-100682
Open Access | Times Cited: 19
Old and New Precipitants in Hepatic Encephalopathy: A New Look at a Field in Continuous Evolution
Daniele Bellafante, Stefania Gioia, Jessica Faccioli, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 3, pp. 1187-1187
Open Access | Times Cited: 17
Antibiotics With or Without Rifaximin for Acute Hepatic Encephalopathy in Critically Ill Patients With Cirrhosis: A Double-Blind, Randomized Controlled (ARiE) Trial
Anand V. Kulkarni, Mahathi Avadhanam, Puja Karandikar, et al.
The American Journal of Gastroenterology (2023) Vol. 119, Iss. 5, pp. 864-874
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top